Neurodegenerative Disease and Dementia – Contact Details

Photo of Neurodegenerative Disease and Dementias Theme lead: Professor James Rowe

Theme lead: Professor James Rowe

As Professor of Cognitive Neurology, James Rowe studies the mechanisms and potential treatments for dementias and neurodegenerative disease including Alzheimer’s disease. Progressive Supranuclear Palsy, Parkinson’s disease and frontotemporal dementia. He trained in medical sciences and experimental psychology at Cambridge, before clinical studies in Oxford and his PhD at the Institute of Neurology, London. After further specialist training in Copenhagen, he returned to Cambridge in 2005. He is Associate Director of DPUK, leading the academic-industrial partnership for experimental medicine. He leads the Centre for Frontotemporal Dementia and the Clinical program within the Centre for Parkinson-plus, together with regional NHS clinics for these disorders. The integration of multimodal brain imaging, genetics, pharmacology and computational modelling provides a powerful platform to understand neurological disease, and to assess the efficacy of novel treatments.

Contactjames.rowe@mrc-cbu.cam.ac.uk

Photo of Dr Caroline Williams-Gray - Neurodegenerative Disease and Dementias co-Theme lead

Theme co-lead: Dr Caroline Williams-Gray

Caroline Williams-Gray is a clinician scientist and neurologist specializing in Parkinson’s disease (PD) and PD-associated dementia. She studied medicine at Cambridge University and then Oxford Clinical School, graduating in 2001, and gained her PhD from Cambridge University in 2008 for studies investigating the cognitive heterogeneity of PD. Following neurology training in Cambridge, Norwich and London, and then a Clinical Lectureship in Cambridge, she was awarded an MRC Clinician Scientist Fellowship in 2018. She leads the Cambridge Parkinson’s Disease Research Clinic, as well as community-based longitudinal cohort studies in PD: these studies provide a platform for clinical phenotyping, genetics, neuroimaging and biomarker studies, all of which contribute to our understanding of disease heterogeneity and facilitate the development of targeted treatment approaches for different PD subtypes. Her research lab has a particular interest in the contribution of the immune system to the progression of neurodegenerative disease and the development of immune-based therapeutics for PD and related conditions.

Contact: chm27@cam.ac.uk

Shaline Fazal

BRC-NDD theme coordinator

Contact: sf618@cam.ac.uk

John O’ Brien

Professor of Old Age Psychiatry and Honorary Consultant Psychiatrist

Franklin Aigbirhio

Director of PET (Radiochemistry) Sciences and Professor of Molecular Imaging Chemistry

Emma Cutting

Senior Clinical Trials Coordinator

Contact: evc26@cam.ac.uk

Roger Barker

Professor Clinical Neuroscience and Honorary Consultant Neurologist

Contact: rab46@cam.ac.uk

Carol Brayne

Director of Cambridge Institute of Public Health

Sir David Klenerman

Professor of biophysical chemistry

David Rubinsztein

Professor of Molecular Neurogenetics

Hugh Markus

Professor of Stroke Medicine

Annelies Quaegebeur

Consultant Neuropathologist

Contact: aq244@cam.ac.uk

Tim Rittman

Senior Clinical Research Associate

Maria Grazia-Spillantini

Professor of Molecular Neurology

Contact: mgs11@cam.ac.uk

Ben Underwood

CPFT honorary consultant old age psychiatrist

Carola Bibiane Schönlieb

Professor of Applied Mathematics

Professor Matthew Lambon Ralph

Professor and Unit Director MRC Cognition and Brain Sciences Unit

Patrick Chinnery

Professor of Neurology, head of the Department of Clinical Neurosciences and an Honorary Consultant Neurologist

© Copyright - NIHR Cambridge Biomedical Research Centre 2025